Uterine washing test to detect ovarian cancer risk
Part of Cancer, Women’s health & pregnancy clinical trials.
This study is testing a new way to find ovarian cancer early. It uses a gentle washing of the uterus (like a Pap test) to collect cells and look for signs of cancer in women who are at high risk because of a BRCA gene mutation. The goal is to see if this method can detect cancer before it spreads, which might help save more lives.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a BRCA1 or BRCA2 gene mutation that increases cancer risk.
- You must be planning to have risk-reducing surgery (removal of ovaries and/or fallopian tubes).
- You must still have your uterus and at least one fallopian tube.
- You must not have had your fallopian tubes tied (tubal ligation) in the past.
- You must not have a history of ovarian or endometrial cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to check for uterine cancer risk in people with Lynch syndrome. You would collect a vaginal sample yourself at home and fill out a health questionnaire, which may help catch warning signs early.
This study checks whether a sample of fluid from the uterus (uterine lavage) can help detect ovarian or fallopian tube cancer. You may join if you are having certain gynecologic surgeries or, in a smaller group, you have a BRCA1/2 mutation.
This study collects tissue samples and medical information from people at higher risk for ovarian cancer or undergoing gynecologic surgery. Researchers use this data to develop better ways to detect and prevent ovarian cancer early.
This study is testing a blood test that may help find ovarian cancer earlier in people with BRCA1 or BRCA2 gene changes. It involves giving blood samples before and after surgery to remove the ovaries and fallopian tubes, or over several years if you've had a precancerous lesion found.
This study looks at whether a standard cervical smear test can help find ovarian cancer earlier. The test searches for genetic changes linked to high-grade serous ovarian cancer in cells collected from the cervix, possibly enabling earlier diagnosis.
This study looks at proteins in urine to help find ovarian cancer earlier and track how the disease changes. It aims to provide a non-invasive way to tell the difference between benign and malignant pelvic masses.
Hear when a new BRCA Hereditary Ovarian Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.